-
1
-
-
84858658381
-
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
-
European Association for the Study of the Liver; European Organization for Research and Treatment of Cancer.
-
European Association for the Study of the Liver; European Organization for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-943.
-
(2012)
J Hepatol
, vol.56
, pp. 908-943
-
-
-
2
-
-
79952231921
-
Management of hepatocellular carcinoma: an update
-
Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. HEPATOLOGY 2011; 53: 1020-1022.
-
(2011)
HEPATOLOGY
, vol.53
, pp. 1020-1022
-
-
Bruix, J.1
Sherman, M.2
-
3
-
-
84873392306
-
Heterogeneity of patients with intermediate (BCLC B) HCC. Proposal for a subclassification to facilitate treatment decisions
-
In press.
-
Bolondi L, Burroughs AK, Dufour JF, Galle P, Mazzaferro V, Piscaglia F, et al. Heterogeneity of patients with intermediate (BCLC B) HCC. Proposal for a subclassification to facilitate treatment decisions. Sem Liver Dis 2012 (In press).
-
(2012)
Sem Liver Dis
-
-
Bolondi, L.1
Burroughs, A.K.2
Dufour, J.F.3
Galle, P.4
Mazzaferro, V.5
Piscaglia, F.6
-
4
-
-
79952039170
-
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization
-
Raoul JL, Sangro B, Forner A, Mazzaferro V, Piscaglia F, Bolondi L, Lencioni R. Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization. Cancer Treat Rev 2010; 37: 212-220.
-
(2010)
Cancer Treat Rev
, vol.37
, pp. 212-220
-
-
Raoul, J.L.1
Sangro, B.2
Forner, A.3
Mazzaferro, V.4
Piscaglia, F.5
Bolondi, L.6
Lencioni, R.7
-
5
-
-
84869231203
-
Response rate and clinical outcome of HCC after first and repeated cTACE performed "on demand"
-
Terzi E, Golfieri R, Piscaglia F, Galassi M, Dazzi A, Leoni S, et al. Response rate and clinical outcome of HCC after first and repeated cTACE performed "on demand". J Hepatol 2012; 57: 1258-1267.
-
(2012)
J Hepatol
, vol.57
, pp. 1258-1267
-
-
Terzi, E.1
Golfieri, R.2
Piscaglia, F.3
Galassi, M.4
Dazzi, A.5
Leoni, S.6
-
6
-
-
80051758429
-
Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version
-
Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, et al. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis 2011; 29: 339-364.
-
(2011)
Dig Dis
, vol.29
, pp. 339-364
-
-
Kudo, M.1
Izumi, N.2
Kokudo, N.3
Matsui, O.4
Sakamoto, M.5
Nakashima, O.6
-
7
-
-
84984586846
-
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
-
Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010; 4: 439-474.
-
(2010)
Hepatol Int
, vol.4
, pp. 439-474
-
-
Omata, M.1
Lesmana, L.A.2
Tateishi, R.3
Chen, P.J.4
Lin, S.M.5
Yoshida, H.6
-
8
-
-
72249087123
-
Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes
-
Salem R, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Ibrahim S, et al. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology 2010; 138: 52-64.
-
(2010)
Gastroenterology
, vol.138
, pp. 52-64
-
-
Salem, R.1
Lewandowski, R.J.2
Mulcahy, M.F.3
Riaz, A.4
Ryu, R.K.5
Ibrahim, S.6
-
9
-
-
80052023374
-
Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation
-
Sangro B, Carpanese L, Cianni R, Golfieri R, Gasparini D, Ezziddin S, et al. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation. HEPATOLOGY 2011; 54: 868-878.
-
(2011)
HEPATOLOGY
, vol.54
, pp. 868-878
-
-
Sangro, B.1
Carpanese, L.2
Cianni, R.3
Golfieri, R.4
Gasparini, D.5
Ezziddin, S.6
-
10
-
-
84876743410
-
Yttrium(90) radioembolization for intermediate-advanced hepatocarcinoma: a phase II study
-
Mazzaferro V, Sposito C, Bhoori S, Romito R, Chiesa C, Morosi C, et al. Yttrium(90) radioembolization for intermediate-advanced hepatocarcinoma: a phase II study. HEPATOLOGY 2013; 57: 1826-1837.
-
(2013)
HEPATOLOGY
, vol.57
, pp. 1826-1837
-
-
Mazzaferro, V.1
Sposito, C.2
Bhoori, S.3
Romito, R.4
Chiesa, C.5
Morosi, C.6
-
11
-
-
57749191711
-
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
-
Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009; 10: 35-43.
-
(2009)
Lancet Oncol
, vol.10
, pp. 35-43
-
-
Mazzaferro, V.1
Llovet, J.M.2
Miceli, R.3
Bhoori, S.4
Schiavo, M.5
Mariani, L.6
|